About UCL
Universal Corporation was established in 1996 and is based in Kikuyu, Kenya. Operations span the pharmaceutical sector, with manufacturing focused on generic drugs. Presence is maintained in Malawi, Mozambique, Zambia, Burundi, Rwanda, Congo, DRC, Sierra Leone, Somalia, Angola, Tanzania, and Uganda. Products encompass antimalarials, antivirals, antibiotics, analgesics, central nervous system medications, and cardiovascular treatments.
- Headquarter Kikuyu, Kenya
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Strides Arcolab
(Feb 08, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of UCL
Unlock access to complete
Software Development Team
3 people
Assistant Team
3 people
Leadership Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of UCL
Detailed funding history for UCL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in UCL
UCL has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Strides Arcolab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules
|
Locked | Locked | Locked |
Investor details for UCL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UCL
Investment portfolio details for UCL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - UCL
Detailed financials for UCL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ucl Comparisons
Peer comparison for UCL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UCL
Detailed competitors of UCL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ucl
Complete news archive for UCL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UCL
UCL was founded in 1996.
UCL is headquartered in Kikuyu, Kenya. It is registered at Kikuyu, Kiambu, Kenya.
Universal Corporation was established in 1996 and is based in Kikuyu, Kenya. Operations span the pharmaceutical sector, with manufacturing focused on generic drugs. Presence is maintained in Malawi, Mozambique, Zambia, Burundi, Rwanda, Congo, DRC, Sierra Leone, Somalia, Angola, Tanzania, and Uganda. Products encompass antimalarials, antivirals, antibiotics, analgesics, central nervous system medications, and cardiovascular treatments.
UCL has 1 investor. Key investors include Strides Arcolab.